Pay in 4 interest-free payments of $5.63 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
This form dissolves under your tongue
2019;317(4):F941F948
Dual GIP and GLP-1 receptor agonist GLP2 improves beta-cell function and insulin sensitivity in type 2 diabetes
As a dual GIP/GLP-1 receptor agonist, it targets two hormonal pathways instead of one
Studies following patients after stopping GLP-1 therapy show weight regain within about 18 months without sustained lifestyle changes
US$ 26.11
US$ 27.53
US$ 27.33
US$ 22.30
US$ 28.64
